ORPHA:780
Rhabdomyosarcoma
- Type
- Disease
- Group
- Disorder
- Inheritance
- Multigenic/multifactorial
- Age of onset
- Childhood
- Status
- active
A malignant soft tissue tumor which develops from cells of striated muscle. It is the most common form of tumor found in children and adolescents.
1
Names in Orphadata languages
12 of 12 languages| Lang | Name | Synonyms |
|---|---|---|
| en | Rhabdomyosarcoma | |
| fr | Rhabdomyosarcome | |
| de | Rhabdomyosarkom | |
| es | Rabdomiosarcoma | |
| it | Rabdomiosarcoma | |
| nl | Rhabdomyosarcoom | |
| pt | Rabdomiossarcoma | |
| pl | Mięsak prążkowanokomórkowy | |
| cs | Rhabdomyosarkom | |
| uk | Рабдоміосаркома | |
| zh | 舌横纹肌肉瘤 | |
| tr | Rabdomyosarkom |
Definition in:
2
Cross-references
qualifier = Orphanet mapping relation| Source | Code | Qualifier | ICD relation | Validation |
|---|---|---|---|---|
| OMIM | 180295 | BTNT | validated | |
| OMIM | 268210 | BTNT | validated | |
| OMIM | 268220 | BTNT | validated | |
| ICD-10 | C49.9 | NTBT | index | validated |
| ICD-11 | 2B55 | E | specific | validated |
| ICD-11 | 2B55.0 | BTNT | specific | validated |
| ICD-11 | 2B55.1 | BTNT | specific | validated |
| ICD-11 | 2B55.2 | BTNT | specific | validated |
| ICD-11 | 2B55.Y | BTNT | attributed | validated |
| MONDO | 0005212 | E | validated | |
| MeSH | D012208 | E | validated | |
| UMLS | C0035412 | E | validated | |
| MedDRA | 10039022 | E | validated |
E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.
3
Classification
Preferential parent (Orphanet linearisation):
Parents in the classifications (2):
- ORPHA:206982Muscular tumor
rare neurological diseases - ORPHA:3394Soft tissue sarcoma
rare neoplastic diseases
4
Genes
0 direct · 11 via subtypesOrphanet records no gene directly on this code.
Recorded by Orphanet on subtypes of this disorder:
| Gene | Subtype | Association | Status | HGNC | Ensembl | OMIM | Locus | Name | Source of validation |
|---|---|---|---|---|---|---|---|---|---|
| SLC67A1 | ORPHA:99757Embryonal rhabdomyosarcoma | Candidate gene tested in | Not yet assessed | HGNC:10964 | ENSG00000110628 | 602631 | 11p15.4 | solute carrier family 67 member 1 | 9520460[PMID] |
| TP53 | ORPHA:99756Alveolar rhabdomyosarcoma | Disease-causing germline mutation(s) in | Assessed | HGNC:11998 | ENSG00000141510 | 191170 | 17p13.1 | tumor protein p53 | 7706467[PMID] |
| TP53 | ORPHA:99757Embryonal rhabdomyosarcoma | Disease-causing germline mutation(s) in | Assessed | HGNC:11998 | ENSG00000141510 | 191170 | 17p13.1 | tumor protein p53 | 7706467[PMID] |
| TP53 | ORPHA:293199Pleomorphic rhabdomyosarcoma | Disease-causing germline mutation(s) in | Assessed | HGNC:11998 | ENSG00000141510 | 191170 | 17p13.1 | tumor protein p53 | 7706467[PMID] |
| DICER1 | ORPHA:99757Embryonal rhabdomyosarcoma | Disease-causing somatic mutation(s) in | Assessed | HGNC:17098 | ENSG00000100697 | 606241 | 14q32.13 | dicer 1, ribonuclease III | 22180160[PMID] |
| NF1 | ORPHA:99756Alveolar rhabdomyosarcoma | Disease-causing somatic mutation(s) in | Assessed | HGNC:7765 | ENSG00000196712 | 613113 | 17q11.2 | neurofibromin 1 | 34166060[PMID] |
| NF1 | ORPHA:99757Embryonal rhabdomyosarcoma | Disease-causing somatic mutation(s) in | Assessed | HGNC:7765 | ENSG00000196712 | 613113 | 17q11.2 | neurofibromin 1 | 34166060[PMID] |
| NF1 | ORPHA:293199Pleomorphic rhabdomyosarcoma | Disease-causing somatic mutation(s) in | Assessed | HGNC:7765 | ENSG00000196712 | 613113 | 17q11.2 | neurofibromin 1 | 34166060[PMID] |
| FOXO1 | ORPHA:99756Alveolar rhabdomyosarcoma | Part of a fusion gene in | Assessed | HGNC:3819 | ENSG00000150907 | 136533 | 13q14.11 | forkhead box O1 | |
| PAX3 | ORPHA:99756Alveolar rhabdomyosarcoma | Part of a fusion gene in | Assessed | HGNC:8617 | ENSG00000135903 | 606597 | 2q36.1 | paired box 3 | |
| PAX7 | ORPHA:99756Alveolar rhabdomyosarcoma | Part of a fusion gene in | Assessed | HGNC:8621 | ENSG00000009709 | 167410 | 1p36.13 | paired box 7 |
5
Prevalence and incidence
2 records| Type | Class | Value | Area | Qualification | Validation | Source |
|---|---|---|---|---|---|---|
| Annual incidence | 1-9 / 1 000 000 | 0.59 / 100 000 | Europe | Value and class | Validated | [EXPERT] |
| Point prevalence | Unknown | — | Worldwide | Class only | Not yet validated | ORPHANET |
Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.
6
HPO phenotypes
Orphanet has no HPO annotation for this code in this release.
7
Sources for this card
- Orphanet page: orpha.net/en/disease/detail/780
- This record as JSON: /data/d/780.json